Edward A Ratovitski Selected Research

Cisplatin (Platino)

5/2015	Phospho-ΔNp63α-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure.
1/2015	Delta Np63 alpha – Responsive microRNA Modulate the Expression of Metabolic Enzymes.
11/2013	Phospho-ΔNp63α regulates AQP3, ALOX12B, CASP14 and CLDN1 expression through transcription and microRNA modulation.
8/2013	Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: at the crossroads of cell life and death.
2/2013	Phospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure.
10/2012	Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
6/2012	Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
3/2012	Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation.
11/2011	Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.
12/2010	Phosphorylated TP63 induces transcription of RPN13, leading to NOS2 protein degradation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward A Ratovitski Research Topics

Disease

21	Neoplasms (Cancer) 04/2017 - 10/2006
12	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2016 - 12/2010
4	Carcinogenesis 11/2013 - 10/2006
3	Squamous Cell Carcinoma of Head and Neck 02/2011 - 10/2004
3	Breast Neoplasms (Breast Cancer) 08/2008 - 10/2006
2	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 08/2016
2	Astrocytoma (Pilocytic Astrocytoma) 01/2017 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 08/2016 - 10/2012
2	Esophageal Squamous Cell Carcinoma 05/2011 - 02/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2010 - 02/2010
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2013
1	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2012
1	Lung Neoplasms (Lung Cancer) 09/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2008
1	Autosomal Dominant 5 Deafness 05/2008

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2008
11	Cisplatin (Platino)FDA LinkGeneric 05/2015 - 12/2010
7	MicroRNAs (MicroRNA)IBA 05/2015 - 10/2012
4	ChromatinIBA 01/2017 - 09/2010
4	SmokeIBA 05/2011 - 07/2010
3	dehydroleucodineIBA 01/2017 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 06/2012 - 09/2010
2	LuciferasesIBA 01/2017 - 08/2016
2	PlatinumIBA 05/2015 - 10/2012
2	EnzymesIBA 01/2015 - 01/2014
2	Protein Isoforms (Isoforms)IBA 03/2012 - 12/2010
2	COOH-terminal signal transamidaseIBA 08/2008 - 10/2006
2	Messenger RNA (mRNA)IBA 08/2008 - 05/2008
1	AntibodiesIBA 01/2017
1	Tumor Protein p73IBA 01/2017
1	Complementary DNA (cDNA)IBA 01/2017
1	chromomycin A2IBA 08/2016
1	psammaplin AIBA 08/2016
1	ilimaquinoneIBA 08/2016
1	Cytostatic AgentsIBA 01/2015
1	ElementsIBA 02/2013
1	coactivator-associated arginine methyltransferase 1IBA 02/2013
1	Co-Repressor ProteinsIBA 02/2013
1	Amino Acids FDA Link 10/2012
1	LipidsIBA 10/2012
1	NucleotidesIBA 10/2012
1	CarbohydratesIBA 10/2012
1	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2011
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2011
1	NF-kappa B (NF-kB)IBA 09/2010
1	Adenosine Triphosphate (ATP)IBA 07/2010
1	API 2IBA 02/2010
1	Pyruvic Acid (Pyruvate)IBA 02/2010
1	Deoxyglucose (2 Deoxy D glucose)IBA 02/2010
1	beta CateninIBA 02/2010
1	Peptides (Polypeptides)IBA 02/2010
1	Oxidoreductases (Dehydrogenase)IBA 02/2010
1	Biomarkers (Surrogate Marker)IBA 05/2008
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 10/2006
1	PaxillinIBA 10/2006
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2004

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 05/2015 - 12/2010
2	Therapeutics 04/2017 - 10/2012